Moon River Moly Ltd. Announces Grant of Stock Options

Rhea-AI Summary

Moon River Moly (OTCQB: MRIVF) announced a grant of stock options totaling 40,000 common shares.

The options include 15,000 for a non-executive employee and 25,000 for a non-executive consultant, at an exercise price of $0.73 per share, exercisable until April 23, 2036.

News Market Reaction – MRIVF

-8.63%

-8.63% Session close to close

In the Apr 24 session, MRIVF declined 8.63%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Toronto, Ontario--(Newsfile Corp. - April 24, 2026) - Moon River Moly Ltd. (TSXV: MOO) (OTCQB: MRIVF) ("Moon River" or the "Company") The Company announces that it has granted stock options entitling the holders to acquire up to an aggregate of 40,000 common shares; including stock options granted to a non-executive employee and a non-executive consultant, to acquire 15,000 and 25,000 common shares respectively, at an exercise price of $0.73 per share until April 23, 2036.

About Moon River
Moon River is a Canadian-based resource company focused on the acquisition, exploration and development of mineral projects. Moon River is focused on the development of the Davidson Property which hosts a large molybdenum-tungsten deposit and is located near Smithers, British Columbia. The Company also holds 25% of one of the largest molybdenum mines in North America, the Endako Mine Complex also located in British Columbia.

For further information, please contact:
Paul Parisotto, President, Chief Executive Officer and Director, at (416) 800-1753 or info@moonrivermoly.com.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking Statements:
This press release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-Looking statements are often identified by terms such as "may", "should", "anticipate", "will", "estimates", "believes", "intends", "expects" and similar expressions, which are intended to identify forward-looking statements. Forward-looking statements reflect the current views of the Company, represent the expectations of the Company as of the date of this news release, and are based on certain assumptions that the Company has made in respect thereof as at the date of this press release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294076

FAQ

What stock options did Moon River Moly (MRIVF) grant on April 24, 2026?

The company granted options to purchase 40,000 common shares. According to the company, those comprise 15,000 for a non-executive employee and 25,000 for a non-executive consultant, all exercisable at $0.73 per share until April 23, 2036.

What is the exercise price and expiry date for MRIVF stock options granted April 24, 2026?

The exercise price is $0.73 per share and the options expire on April 23, 2036. According to the company, these terms apply to all 40,000 options granted to the employee and consultant.

How many options did the non-executive employee and consultant receive from MRIVF?

The non-executive employee received 15,000 options and the non-executive consultant received 25,000 options. According to the company, the combined total of granted options is 40,000 common shares.

Do the MRIVF option grants on April 24, 2026 create immediate dilution for shareholders?

The grants permit issuance of up to 40,000 common shares if exercised, which could dilute shareholders only upon exercise. According to the company, options are exercisable at $0.73 until April 23, 2036, creating potential future dilution if exercised.

Where can investors find the terms of the MRIVF option grant dated April 24, 2026?

Key terms are the 40,000-share total, split of 15,000 and 25,000, exercise price $0.73, and expiry April 23, 2036. According to the company, these are the disclosed grant details for investors to review.